Top Picks
Show
Signal
Opinion
Expert
TOP PICK
TOP PICK
April 16, 2021
This is a low hanging fruit that has low risk but has good upside potential with dividend. They will benefit from their network updates and 5G. There will be consolidation with Rogers and Shaw which will help their business. You will get a nice dividend. A great all weather stock. (Analysts’ price target is $60.09)
Show full opinionHide full opinion
This is a low hanging fruit that has low risk but has good upside potential with dividend. They will benefit from their network updates and 5G. There will be consolidation with Rogers and Shaw which will help their business. You will get a nice dividend. A great all weather stock. (Analysts’ price target is $60.09)
TOP PICK
TOP PICK
April 16, 2021
The banks are all benefitting from market sensitive fees like investment banking and yield curve. They are trading at 10.3x 2022. A good risk-reward play. Balance sheet looks good. They will buy back their shares or increase their dividends in the coming months. (Analysts’ price target is $118.89)
Show full opinionHide full opinionThe banks are all benefitting from market sensitive fees like investment banking and yield curve. They are trading at 10.3x 2022. A good risk-reward play. Balance sheet looks good. They will buy back their shares or increase their dividends in the coming months. (Analysts’ price target is $118.89)
TOP PICK
TOP PICK
April 16, 2021
Essential to our way of life. One of the companies that moves oil. Pipelines are very hard to build. A scarce resource that has coveted assets. Has a much better balance sheet, moving to ESG, and line 3 is getting support. Trading at 14.9x PE 2023 with an 8% EPS growth rate. (Analysts’ price target is $52.58)
Show full opinionHide full opinionEssential to our way of life. One of the companies that moves oil. Pipelines are very hard to build. A scarce resource that has coveted assets. Has a much better balance sheet, moving to ESG, and line 3 is getting support. Trading at 14.9x PE 2023 with an 8% EPS growth rate. (Analysts’ price target is $52.58)
TOP PICK
TOP PICK
April 15, 2021
Stockchase Research Editor: Michael O'Reilly LOVE is a maker of foam filled furniture that is washable and modular. It uses Best Buy and Costco as their largest retailing arms. Recently reported sales were up 41%, revenue up 66%, which handily beat analyst expectations. Quarterly EPS at $1.33 beat expectation by $0.79. It is building cash reserves and has zero debt. We would buy this with a stop loss at $49, looking to achieve $76 -- upside potential over 20%. And besides, who doesn't want to have a little LOVE? Yield 0% (Analysts’ price target is $75.71)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly LOVE is a maker of foam filled furniture that is washable and modular. It uses Best Buy and Costco as their largest retailing arms. Recently reported sales were up 41%, revenue up 66%, which handily beat analyst expectations. Quarterly EPS at $1.33 beat expectation by $0.79. It is building cash reserves and has zero debt. We would buy this with a stop loss at $49, looking to achieve $76 -- upside potential over 20%. And besides, who doesn't want to have a little LOVE? Yield 0% (Analysts’ price target is $75.71)
TOP PICK
TOP PICK
April 15, 2021
Stockchase Research Editor: Michael O'Reilly LRN is a K-12 technology based education company. Its revenue growth has averaged over 11% for the past five years and it is expected schools will continue to have blended online teaching even after the pandemic. Trading at 27x earnings, it is cheap compared to peers at 45x. Over 85% of the shares are held by large institutions, giving it more staying power. We would buy this with a stop loss at $21, looking to achieve $44 -- upside potential over 39%. Yield 0% (Analysts’ price target is $43.75)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly LRN is a K-12 technology based education company. Its revenue growth has averaged over 11% for the past five years and it is expected schools will continue to have blended online teaching even after the pandemic. Trading at 27x earnings, it is cheap compared to peers at 45x. Over 85% of the shares are held by large institutions, giving it more staying power. We would buy this with a stop loss at $21, looking to achieve $44 -- upside potential over 39%. Yield 0% (Analysts’ price target is $43.75)
TOP PICK
TOP PICK
April 15, 2021
Stockchase Research Editor: Michael O'Reilly NEM is a good defensive holding -- a well funded, high level dividend; inflation protection; and market uncertainty protection. As a miner, primarily of gold, with reserves over 94 million ounces, it checks a lot of boxes. Trading at 20x earnings, it is cheaper than its peers at 26x. Over 75% of the shares are held by large institutions, giving it more staying power. Its dividend is backed by a payout ratio of 57%. We would buy this with a stop loss at $52, looking to achieve $80 -- upside exceeding 23%. Yield 3.56% (Analysts’ price target is $72.91)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly NEM is a good defensive holding -- a well funded, high level dividend; inflation protection; and market uncertainty protection. As a miner, primarily of gold, with reserves over 94 million ounces, it checks a lot of boxes. Trading at 20x earnings, it is cheaper than its peers at 26x. Over 75% of the shares are held by large institutions, giving it more staying power. Its dividend is backed by a payout ratio of 57%. We would buy this with a stop loss at $52, looking to achieve $80 -- upside exceeding 23%. Yield 3.56% (Analysts’ price target is $72.91)
TOP PICK
TOP PICK
April 15, 2021
Should do well going forward in their 5 areas: property, infrastructure, credit, renewables, private equity. Will benefit as more institutions allocate funds to the types of alternative assets that BAM holds. Yield is 1.14%. (Analysts’ price target is $66.95)
Show full opinionHide full opinionShould do well going forward in their 5 areas: property, infrastructure, credit, renewables, private equity. Will benefit as more institutions allocate funds to the types of alternative assets that BAM holds. Yield is 1.14%. (Analysts’ price target is $66.95)
TOP PICK
TOP PICK
April 15, 2021
Hit by the pandemic, but Disney Plus did well through the crisis. Huge content library that they can stream. A reopening play on the parks, plus the new growth path of streaming. Positive future growth prospects. No dividend. (Analysts’ price target is $204.86)
Show full opinionHide full opinionHit by the pandemic, but Disney Plus did well through the crisis. Huge content library that they can stream. A reopening play on the parks, plus the new growth path of streaming. Positive future growth prospects. No dividend. (Analysts’ price target is $204.86)
TOP PICK
TOP PICK
April 15, 2021
25% of business comes from the US, where capital market activity is quite robust. Stock price has moved, but more to come as the Canadian and US economies open up. Still trades at a reasonable multiple. Eventually dividends and share buybacks will resume. Unused loan reserves strengthen its capital base. Yield is 3.68%. (Analysts’ price target is $123.06)
Show full opinionHide full opinion25% of business comes from the US, where capital market activity is quite robust. Stock price has moved, but more to come as the Canadian and US economies open up. Still trades at a reasonable multiple. Eventually dividends and share buybacks will resume. Unused loan reserves strengthen its capital base. Yield is 3.68%. (Analysts’ price target is $123.06)
TOP PICK
TOP PICK
April 14, 2021
Lots of pent-up demand for eyeglass lenses and endoscopy procedures. Pent-up demand is one of his themes for the early stage of an economic recovery. (Price target is in yuan.) Yield is 0.65%. (Analysts’ price target is $14486.36)
Show full opinionHide full opinionLots of pent-up demand for eyeglass lenses and endoscopy procedures. Pent-up demand is one of his themes for the early stage of an economic recovery. (Price target is in yuan.) Yield is 0.65%. (Analysts’ price target is $14486.36)
TOP PICK
TOP PICK
April 14, 2021
Commercial property insurance is getting better. A hardening price environment. One of the 3 largest global reinsurers. Strongest balance sheet, so can charge the highest prices and give the most coverage. Strong cyclical exposure is a good play on recovering economy. Returns capital to shareholders by buying back shares. No dividend. (Analysts’ price target is $281.00)
Show full opinionHide full opinionCommercial property insurance is getting better. A hardening price environment. One of the 3 largest global reinsurers. Strongest balance sheet, so can charge the highest prices and give the most coverage. Strong cyclical exposure is a good play on recovering economy. Returns capital to shareholders by buying back shares. No dividend. (Analysts’ price target is $281.00)
TOP PICK
TOP PICK
April 14, 2021
Construction chemicals. One of key beneficiaries of European green new deal. Timely. Very strong balance sheet, proven record of acquisitions, improving margins. The strong Swiss currency has been a challenge, but he can live with this. (Price target is in Swiss francs.) Yield is 0.94%. (Analysts’ price target is $289.95)
Show full opinionHide full opinionConstruction chemicals. One of key beneficiaries of European green new deal. Timely. Very strong balance sheet, proven record of acquisitions, improving margins. The strong Swiss currency has been a challenge, but he can live with this. (Price target is in Swiss francs.) Yield is 0.94%. (Analysts’ price target is $289.95)
TOP PICK
TOP PICK
April 13, 2021
Stockchase Research Editor: Michael O'Reilly SLP is a $1.2 billion healthcare software company that provides modeling and simulation products to drug companies and biotechs and other sectors. Recently reported revenues were up 27% on the year and net income rose 49%. Their recurring revenue model helps produce 78% gross margins and it carries minimal long term debt. It pays a small dividend, backed by a 45% payout ratio. We would buy this with a stop loss at $40, looking to achieve $83 -- upside potential over 40%. Yield 0.38% (Analysts’ price target is $82.50)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly SLP is a $1.2 billion healthcare software company that provides modeling and simulation products to drug companies and biotechs and other sectors. Recently reported revenues were up 27% on the year and net income rose 49%. Their recurring revenue model helps produce 78% gross margins and it carries minimal long term debt. It pays a small dividend, backed by a 45% payout ratio. We would buy this with a stop loss at $40, looking to achieve $83 -- upside potential over 40%. Yield 0.38% (Analysts’ price target is $82.50)
TOP PICK
TOP PICK
April 13, 2021
Stockchase Research Editor: Michael O'Reilly As consumers become more comfortable with online commerce, SHOP is well positioned to continue to see significant growth. It offers retailers an efficient way to sell directly and it collects recurring revenues through subscription fees. Earnings will be reported April 28 and the market expects EPS of $0.71 US and revenue of over $848 million US. Growth is expected to be modest compared to more than 1200% last year. Its success as a Canadian company has allowed it to build its cash position to over $2 billion US. We would buy this with a stop loss at $1000, looking to achieve $2000 -- upside potential over 30%. Yield 0% (Analysts’ price target is $2002.76)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly As consumers become more comfortable with online commerce, SHOP is well positioned to continue to see significant growth. It offers retailers an efficient way to sell directly and it collects recurring revenues through subscription fees. Earnings will be reported April 28 and the market expects EPS of $0.71 US and revenue of over $848 million US. Growth is expected to be modest compared to more than 1200% last year. Its success as a Canadian company has allowed it to build its cash position to over $2 billion US. We would buy this with a stop loss at $1000, looking to achieve $2000 -- upside potential over 30%. Yield 0% (Analysts’ price target is $2002.76)
TOP PICK
TOP PICK
April 13, 2021
Stockchase Research Editor: Michael O'Reilly TLT is an ETF that represents US 20 long term treasury bonds of a term of 20+ years. Yields on these treasuries have been rising steadily since the pandemic based market collapse last March from under 1.00% to 2.25% now. This is a precautionary holding, to protect in the event of another market retracement. With the S&P500 trading at 22.4x earnings the market is at risk to correction if this season's reported earnings disappoint. As we consider this a hedge, we do not set a target or stop-loss, but instead will monitor trends in the underlying yield as a signal. Yield 1.61%
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly TLT is an ETF that represents US 20 long term treasury bonds of a term of 20+ years. Yields on these treasuries have been rising steadily since the pandemic based market collapse last March from under 1.00% to 2.25% now. This is a precautionary holding, to protect in the event of another market retracement. With the S&P500 trading at 22.4x earnings the market is at risk to correction if this season's reported earnings disappoint. As we consider this a hedge, we do not set a target or stop-loss, but instead will monitor trends in the underlying yield as a signal. Yield 1.61%
TOP PICK
TOP PICK
April 13, 2021
Two-thirds of their business is in North America. They have pricing power now (at times in a cycle insurers don't). CB's combined ratio is very strong. It trades at 1.3x book, reasonable for an insurer, and at 15x earnings. He's done well holding this for a while. (Analysts’ price target is $180.59)
Show full opinionHide full opinionTwo-thirds of their business is in North America. They have pricing power now (at times in a cycle insurers don't). CB's combined ratio is very strong. It trades at 1.3x book, reasonable for an insurer, and at 15x earnings. He's done well holding this for a while. (Analysts’ price target is $180.59)
TOP PICK
TOP PICK
April 13, 2021
An infrastructure company in telecoms; their biggest customers are telecoms like Verizon and Comcast. They string the contintent for 5G capability. Warning: It's a lumpy business, because it's bsed on fixed costs. However, Dycom is getting a lot of positive attention because they are the go-to business to lay the fibre optics for the coming 5G revolution. This can easily earn $6/share, so it's not expensive now. (Analysts’ price target is $102.00)
An infrastructure company in telecoms; their biggest customers are telecoms like Verizon and Comcast. They string the contintent for 5G capability. Warning: It's a lumpy business, because it's bsed on fixed costs. However, Dycom is getting a lot of positive attention because they are the go-to business to lay the fibre optics for the coming 5G revolution. This can easily earn $6/share, so it's not expensive now. (Analysts’ price target is $102.00)
TOP PICK
TOP PICK
April 13, 2021
Copper is showing life again at over $4/pound and will stay at high levels. A highly profitable company. Commodities have done very well in the past year. The price could rise long term. One big reason is the electrification of cars which need 2-4 times as much copper as a gas-powered car. (Analysts’ price target is $39.03)
Show full opinionHide full opinionCopper is showing life again at over $4/pound and will stay at high levels. A highly profitable company. Commodities have done very well in the past year. The price could rise long term. One big reason is the electrification of cars which need 2-4 times as much copper as a gas-powered car. (Analysts’ price target is $39.03)
TOP PICK
TOP PICK
April 12, 2021
Pays a 2.5% dividend, but generates a lot of cash flow at 17.1% cash flow yield. Earnings to grow 14% in 2022 or 11.7x PE. Analysts have bumped up earnings estimates by 2% in the past 90 days. An analyst today said this is trading at historic oversold levels in the past decade. (Analysts’ price target is $190.58)
Show full opinionHide full opinionPays a 2.5% dividend, but generates a lot of cash flow at 17.1% cash flow yield. Earnings to grow 14% in 2022 or 11.7x PE. Analysts have bumped up earnings estimates by 2% in the past 90 days. An analyst today said this is trading at historic oversold levels in the past decade. (Analysts’ price target is $190.58)
TOP PICK
TOP PICK
April 12, 2021
They're involved in Covid testing. Sales should more than double by Sept. 2021 year end to $25 million with a further 32% growth in sales of 2022 to $34 million. He expects Covid testing will continue to be common for employees and travellers. This stock could double from current levels. Other analysts target even higher, but this is a speculative stock. (Analysts’ price target is $0.80)
Show full opinionHide full opinionThey're involved in Covid testing. Sales should more than double by Sept. 2021 year end to $25 million with a further 32% growth in sales of 2022 to $34 million. He expects Covid testing will continue to be common for employees and travellers. This stock could double from current levels. Other analysts target even higher, but this is a speculative stock. (Analysts’ price target is $0.80)
TOP PICK
TOP PICK
April 12, 2021
Lumber prices have soared YOY over 300%. Free cash flow yield at 14.4% is very high. The latest report said that earnings were up 50% and earnings are forecast to grow 35% to $16 ROE in 2021 at a PE of 6.4x. Analyst estimates have jumped 81%. (Analysts’ price target is $112.68)
Show full opinionHide full opinionLumber prices have soared YOY over 300%. Free cash flow yield at 14.4% is very high. The latest report said that earnings were up 50% and earnings are forecast to grow 35% to $16 ROE in 2021 at a PE of 6.4x. Analyst estimates have jumped 81%. (Analysts’ price target is $112.68)
TOP PICK
TOP PICK
April 9, 2021
They participate in the spread when the deal is announced. Shaw is trading 24% the price Rogers has offered. This is due to the fear of regulatory intervention. Thinks that the real concern is on the wireless side, and this deal works without the wireless side. They can divest Shaw's wireless side and still be a good deal. Thinks there is a 85% chance of the deal going through. (Analysts’ price target is $37.92)
They participate in the spread when the deal is announced. Shaw is trading 24% the price Rogers has offered. This is due to the fear of regulatory intervention. Thinks that the real concern is on the wireless side, and this deal works without the wireless side. They can divest Shaw's wireless side and still be a good deal. Thinks there is a 85% chance of the deal going through. (Analysts’ price target is $37.92)
TOP PICK
TOP PICK
April 9, 2021
In a transformation to digital by investing in wealth business acuiqistions. International exposure is being retooled too. Likes it in general since banks have tail winds like yield curve steepening, ability to buy back stocks again, etc. One of the cheaper banks. The wealth business is showing good returns. Good value and volatility measures. (Analysts’ price target is $80.45)
Show full opinionHide full opinionIn a transformation to digital by investing in wealth business acuiqistions. International exposure is being retooled too. Likes it in general since banks have tail winds like yield curve steepening, ability to buy back stocks again, etc. One of the cheaper banks. The wealth business is showing good returns. Good value and volatility measures. (Analysts’ price target is $80.45)
TOP PICK
TOP PICK
April 9, 2021
Likes it for the non-bank financial play. In a bull cycle, one area to look at is broker dealers and asset managers. They are a wealth planner. Relatively new holding for him. Good price momentum and very reasonably priced at 8x enterprise value, 6.8x free cashflow, 16x earnings. Great balance sheet and using it for doing mergers. Fragmented business that can be consolidated. (Analysts’ price target is $249.46)
Show full opinionHide full opinionLikes it for the non-bank financial play. In a bull cycle, one area to look at is broker dealers and asset managers. They are a wealth planner. Relatively new holding for him. Good price momentum and very reasonably priced at 8x enterprise value, 6.8x free cashflow, 16x earnings. Great balance sheet and using it for doing mergers. Fragmented business that can be consolidated. (Analysts’ price target is $249.46)
TOP PICK
TOP PICK
April 8, 2021
Stockchase Research Editor: Michael O'Reilly MRNA is now a well known name in the production of COVID-19 vaccine and is only one of three that have received approval in the US. Purchase agreements amounted to $18 billion, allowing cash flow reserves of the company to balloon. The company is now working on a single-dose product that does not require extreme refrigeration. The pullback in the share price, and a forward PE of 9x earnings, offers a good entry level here. We would buy this with a stop loss at $90, looking to achieve $175 -- upside potential of 29%. Yield 0% (Analysts’ price target is $174.25)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly MRNA is now a well known name in the production of COVID-19 vaccine and is only one of three that have received approval in the US. Purchase agreements amounted to $18 billion, allowing cash flow reserves of the company to balloon. The company is now working on a single-dose product that does not require extreme refrigeration. The pullback in the share price, and a forward PE of 9x earnings, offers a good entry level here. We would buy this with a stop loss at $90, looking to achieve $175 -- upside potential of 29%. Yield 0% (Analysts’ price target is $174.25)
TOP PICK
TOP PICK
April 8, 2021
Stockchase Research Editor: Michael O'Reilly The semiconductor space saw global chip sales up over 14% last year and there is now a global shortage of supply. UMC is a Taiwan based chip producer and recently released sales were up 14%. It has beat earnings estimates in each of the past three reporting cycles. It trades at 31x earnings, cheap compared to its peers at 68x. It also pays a small dividend. We would buy this with a stop loss at $7, looking achieve $11.50 -- upside potential over 20%. Yield 1.56% (Analysts’ price target is $11.55)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly The semiconductor space saw global chip sales up over 14% last year and there is now a global shortage of supply. UMC is a Taiwan based chip producer and recently released sales were up 14%. It has beat earnings estimates in each of the past three reporting cycles. It trades at 31x earnings, cheap compared to its peers at 68x. It also pays a small dividend. We would buy this with a stop loss at $7, looking achieve $11.50 -- upside potential over 20%. Yield 1.56% (Analysts’ price target is $11.55)
TOP PICK
TOP PICK
April 8, 2021
Stockchase Research Editor: Michael O'Reilly VIAC is a media monster. Recently reported earnings beat analyst expectations and showed streaming sales were up over 70% and operating cash flow was $2.2 billion and cash reserves are now over $3 billion. Recent stock price volatility has been associated to a forced liquidation by hedge fund that impacted several other unrelated entities. This creates a good entry point as it is now trading at under 20x earnings, compared to peers at over 45x. It pays a modest dividend, backed by a payout ratio under 25% of cash flow. We would buy this with a stop loss at $25, looking to achieve $57.50 -- upside potential over 32%. Yield 2.19% (Analysts’ price target is $57.48)
Show full opinionHide full opinionStockchase Research Editor: Michael O'Reilly VIAC is a media monster. Recently reported earnings beat analyst expectations and showed streaming sales were up over 70% and operating cash flow was $2.2 billion and cash reserves are now over $3 billion. Recent stock price volatility has been associated to a forced liquidation by hedge fund that impacted several other unrelated entities. This creates a good entry point as it is now trading at under 20x earnings, compared to peers at over 45x. It pays a modest dividend, backed by a payout ratio under 25% of cash flow. We would buy this with a stop loss at $25, looking to achieve $57.50 -- upside potential over 32%. Yield 2.19% (Analysts’ price target is $57.48)
TOP PICK
TOP PICK
April 8, 2021
Inflation indexed bonds. Inflation will run hot for at least another 12-18 months. Fees are incredibly low, high liquidity. Benefits from inflation increases. Can't know what's going to happen long term, but you will benefit in the short term from this type of investment. Yield is 1.6%.
Show full opinionHide full opinionInflation indexed bonds. Inflation will run hot for at least another 12-18 months. Fees are incredibly low, high liquidity. Benefits from inflation increases. Can't know what's going to happen long term, but you will benefit in the short term from this type of investment. Yield is 1.6%.
TOP PICK
TOP PICK
April 8, 2021
A recovery story. Best in class, best assets. Theme of stay at home will wane. There's a more hybrid solution, and its stable of smaller tech and healthcare tenants will benefit. Trades at a 15% discount to NAV. Yield is 4.04%. (Analysts’ price target is $45.23)
Show full opinionHide full opinionA recovery story. Best in class, best assets. Theme of stay at home will wane. There's a more hybrid solution, and its stable of smaller tech and healthcare tenants will benefit. Trades at a 15% discount to NAV. Yield is 4.04%. (Analysts’ price target is $45.23)
TOP PICK
TOP PICK
April 8, 2021
Digital and e-commerce transition. Cheap relative to its space and on an absolute basis. Having Shoppers as an asset is so powerful. Yield is 1.9%. (Analysts’ price target is $75.33)
Show full opinionHide full opinionDigital and e-commerce transition. Cheap relative to its space and on an absolute basis. Having Shoppers as an asset is so powerful. Yield is 1.9%. (Analysts’ price target is $75.33)
